TITANBIOSpecialty Chemicals
Titan Bio Tech Ltd — Cash Flow Statement
₹457.70
+4.87%
Titan Bio Tech Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 10.68 Cr | 1.46 Cr | 7.71 Cr | 8.36 Cr | — |
| Repayment Of Debt | -0.27 Cr | — | -0.78 Cr | -0.75 Cr | -9.75 Cr |
| Capital Expenditure | -9.44 Cr | -19.69 Cr | -13.46 Cr | -13.68 Cr | — |
| End Cash Position | 5.13 Cr | 2.84 Cr | 4.86 Cr | 6.81 Cr | — |
| Beginning Cash Position | 2.84 Cr | 4.86 Cr | 6.81 Cr | 5.31 Cr | — |
| Changes In Cash | 2.29 Cr | -2.02 Cr | -1.95 Cr | 1.51 Cr | — |
| Financing Cash Flow | -7.96 Cr | -2.87 Cr | -2.40 Cr | -4.10 Cr | — |
| Interest Paid Cff | -0.80 Cr | -1.17 Cr | -0.75 Cr | -0.87 Cr | — |
| Cash Dividends Paid | -1.65 Cr | -1.49 Cr | -1.24 Cr | -1.24 Cr | — |
| Net Issuance Payments Of Debt | -5.07 Cr | 0.17 Cr | -0.53 Cr | -1.74 Cr | — |
| Net Short Term Debt Issuance | -4.80 Cr | 0.02 Cr | 0.25 Cr | -0.99 Cr | — |
| Net Long Term Debt Issuance | -0.27 Cr | 0.15 Cr | -0.78 Cr | -0.75 Cr | — |
| Long Term Debt Payments | -0.27 Cr | — | -0.78 Cr | -0.75 Cr | -9.75 Cr |
| Investing Cash Flow | -9.87 Cr | -20.30 Cr | -20.73 Cr | -16.44 Cr | — |
| Net Investment Purchase And Sale | -1.30 Cr | -11.60 Cr | -7.55 Cr | -2.76 Cr | — |
| Sale Of Investment | 0.01 Cr | 0.00 | — | — | — |
| Purchase Of Investment | -1.32 Cr | -11.60 Cr | -7.55 Cr | -2.76 Cr | — |
| Net Intangibles Purchase And Sale | -0.05 Cr | -0.04 Cr | -72000.00 | — | — |
| Sale Of Intangibles | 68000.00 | — | — | — | — |
| Purchase Of Intangibles | -0.05 Cr | -0.04 Cr | -72000.00 | — | — |
| Net PPE Purchase And Sale | -8.53 Cr | -8.67 Cr | -13.16 Cr | -13.68 Cr | — |
| Sale Of PPE | 0.86 Cr | 10.98 Cr | 0.29 Cr | — | — |
| Purchase Of PPE | -9.39 Cr | -19.65 Cr | -13.46 Cr | -13.68 Cr | — |
| Operating Cash Flow | 20.12 Cr | 21.15 Cr | 21.18 Cr | 22.04 Cr | — |
| Taxes Refund Paid | -5.99 Cr | -7.87 Cr | -7.50 Cr | -7.12 Cr | — |
| Change In Working Capital | -3.55 Cr | -7.28 Cr | -2.96 Cr | -3.33 Cr | — |
| Change In Other Current Liabilities | 0.95 Cr | 0.67 Cr | 1.92 Cr | — | — |
| Change In Other Current Assets | -1.09 Cr | 1.18 Cr | -0.26 Cr | — | — |
| Change In Payable | 1.85 Cr | -2.18 Cr | 1.39 Cr | 2.49 Cr | — |
| Change In Inventory | -5.15 Cr | -9.40 Cr | -1.49 Cr | -7.85 Cr | — |
| Change In Receivables | -0.10 Cr | 2.45 Cr | -4.52 Cr | 2.03 Cr | — |
| Other Non Cash Items | 0.80 Cr | 1.17 Cr | 0.75 Cr | 0.87 Cr | — |
| Deferred Tax | -30000.00 | 0.33 Cr | 0.03 Cr | 3000.00 | — |
| Depreciation And Amortization | 4.17 Cr | 3.33 Cr | 2.60 Cr | 2.37 Cr | — |
| Depreciation | 4.17 Cr | 3.33 Cr | 2.57 Cr | 2.35 Cr | — |
| Pension And Employee Benefit Expense | 0.32 Cr | 0.03 Cr | 0.31 Cr | 0.28 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 38000.00 | -0.09 Cr | -0.17 Cr | — | — |
| Net Income From Continuing Operations | 24.37 Cr | 31.53 Cr | 28.12 Cr | 28.97 Cr | — |
| Issuance Of Debt | — | 0.15 Cr | — | 2.73 Cr | — |
| Long Term Debt Issuance | — | 0.15 Cr | — | 2.73 Cr | — |
| Provisionand Write Offof Assets | — | 0.33 Cr | 0.31 Cr | 0.28 Cr | — |
| Amortization Cash Flow | — | 0.03 Cr | 0.03 Cr | 0.02 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | — | 3000.00 | 1000.00 | — |
| Issuance Of Capital Stock | — | — | — | 5.64 Cr | 0.00 |
| Net Other Financing Charges | — | — | — | 5.64 Cr | — |
| Net Common Stock Issuance | — | — | — | 5.64 Cr | 0.00 |
| Common Stock Issuance | — | — | — | 5.64 Cr | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Titan Bio Tech Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.